Skip to main content
PMC home page
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1968 Jul;33(3):457–471. doi: 10.1111/j.1476-5381.1968.tb00494.x

Some studies of the effects of chlorpromazine, reserpine and dihydroxyphenylalanine on the concentrations of homovanillic acid, 3,4-dihydroxyphenylacetic acid and 5-hydroxyindol-3-ylacetic acid in ventricular cerebrospinal fluid of the dog using the technique of serial sampling of the cerebrospinal fluid.

H C Guldberg, C M Yates
PMCID: PMC1570240  PMID: 5728318

Full text

PDF
458

Images in this article

463Fig. 1
on p.463

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDEN N. E., ROOS B. E., WERDINIUS B. On the occurrence of homovanillic acid in brain and cerebrospinal fluid and its determination by a fluorometric method. Life Sci. 1963 Jul;(7):448–458. doi: 10.1016/0024-3205(63)90132-2. [DOI] [PubMed] [Google Scholar]
  2. ASHCROFT G. W., SHARMAN D. F. Drug-induced changes in the concentration of 5-OR indolyl compounds in cerebrospinal fluid and caudate nucleus. Br J Pharmacol Chemother. 1962 Aug;19:153–160. doi: 10.1111/j.1476-5381.1962.tb01436.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ashcroft G. W., Crawford T. B., Dow R. C., Guldberg H. C. Homovanillic acid, 3,4-dihydroxyphenylacetic acid and 5-hydroxyindol-3-ylacetic acid in serial samples of cerebrospinal fluid from the lateral ventricle of the dog. Br J Pharmacol Chemother. 1968 Jul;33(3):441–456. doi: 10.1111/j.1476-5381.1968.tb00493.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BERTLER A., FALCK B., ROSENGREN E. THE DIRECT DEMONSTRATION OF A BARRIER MECHANISM IN THE BRAIN CAPILLARIES. Acta Pharmacol Toxicol (Copenh) 1963;20:317–321. doi: 10.1111/j.1600-0773.1964.tb01752.x. [DOI] [PubMed] [Google Scholar]
  5. BERTLER A., ROSENGREN E. Occurrence and distribution of catechol amines in brain. Acta Physiol Scand. 1959 Dec 12;47:350–361. [PubMed] [Google Scholar]
  6. CARLSSON A., HILLARP N. A. Formation of phenolic acids in brain after administration of 3,4-dihydroxyphenylalanine. Acta Physiol Scand. 1962 May;55:95–100. doi: 10.1111/j.1748-1716.1962.tb02422.x. [DOI] [PubMed] [Google Scholar]
  7. CARLSSON A., LINDQVIST M. EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN. Acta Pharmacol Toxicol (Copenh) 1963;20:140–144. doi: 10.1111/j.1600-0773.1963.tb01730.x. [DOI] [PubMed] [Google Scholar]
  8. CARLSSON A., LINDQVIST M., MAGNUSSON T., WALDECK B. On the presence of 3-hydroxytyramine in brain. Science. 1958 Feb 28;127(3296):471–471. doi: 10.1126/science.127.3296.471. [DOI] [PubMed] [Google Scholar]
  9. Da Prada M., Pletscher A. On the mechanism of chlorpromazine-induced changes of cerebral homovanillic acid levels. J Pharm Pharmacol. 1966 Sep;18(9):628–630. doi: 10.1111/j.2042-7158.1966.tb07948.x. [DOI] [PubMed] [Google Scholar]
  10. GEY K. F., PLETSCHER A. EFFECTS OF CHLORPROMAZINE ON THE METABOLISM OF DL-2-C14-DOPA IN THE RAT. J Pharmacol Exp Ther. 1964 Sep;145:337–343. [PubMed] [Google Scholar]
  11. HOLZER G., HORNYKIEWICZ O. [On dopamine (hydroxytyramine) metabolism in the rat brain]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1959;237:27–33. [PubMed] [Google Scholar]
  12. Juorio A. V., Sharman D. F., Trajkov T. The effect of drugs on the homovanillic acid content of the corpus striatum of some rodents. Br J Pharmacol Chemother. 1966 Feb;26(2):385–392. doi: 10.1111/j.1476-5381.1966.tb01918.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. LAVERTY R., SHARMAN D. F. MODIFICATION BY DRUGS OF THE METABOLISM OF 3,4-DIHYDROXYPHENYLETHYLAMINE, NORADRENALINE AND 5-HYDROXYTRYPTAMINE IN THE BRAIN. Br J Pharmacol Chemother. 1965 Jun;24:759–772. doi: 10.1111/j.1476-5381.1965.tb01632.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. LAVERTY R., SHARMAN D. F. THE ESTIMATION OF SMALL QUANTITIES OF 3,4-DIHYDROXYPHENYLETHYLAMINE IN TISSUES. Br J Pharmacol Chemother. 1965 Apr;24:538–548. doi: 10.1111/j.1476-5381.1965.tb01744.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. PLETSCHER A., GEY K. F. Topographical differences in the cerebral metabolism of DL-2-14C-3,4-dihydroxphenylalanine. Experientia. 1962 Nov 15;18:512–513. doi: 10.1007/BF02151603. [DOI] [PubMed] [Google Scholar]
  16. ROOS B. E., WERDINIUS B. Effect of reserpine on the level of 5-hydroxyindoleacetic acid in brain. Life Sci. 1962 Mar;1:105–107. doi: 10.1016/0024-3205(62)90037-1. [DOI] [PubMed] [Google Scholar]
  17. ROSENGREN E. On the role of monoamine oxidase for the inactivation of dopamine in brain. Acta Physiol Scand. 1960 Aug 25;49:370–375. doi: 10.1111/j.1748-1716.1960.tb01959.x. [DOI] [PubMed] [Google Scholar]
  18. Sharman D. F. Changes in the metabolism of 3,4-dihydroxyphenylethylamine (dopamine) in the striatum of the mouse induced by drugs. Br J Pharmacol Chemother. 1966 Nov;28(2):153–163. doi: 10.1111/j.1476-5381.1966.tb01881.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. WEIL-MALHERBE H., WHITBY L. G., AXELROD J. The uptake of circulating [3H]norepinephrine by the pituitary gland and various areas of the brain. J Neurochem. 1961 Oct;8:55–64. doi: 10.1111/j.1471-4159.1961.tb13526.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES